Testing effectiveness (Phase 2)Study completedNCT00230074
What this trial is testing
A Long-term Extension Study of TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis(ALS)
Who this might be right for
Amyotrophic Lateral Sclerosis
Novartis 350